Immupharma Attending Bio-europe
ImmuPharma PLC announced that its CEO, Tim McCarthy, COO, Dr. Tim Franklin, and CSO, Dr. Sebastien Goudreau, will attend the Bio-Europe Conference in Vienna from November 3-5, 2025. The Bio-Europe conference is the 31st annual biopharma partnering event, expecting over 5,700 life science professionals representing more than 3,000 companies across 60+ countries. The event is anticipated to facilitate more than 30,000 one-to-one meetings.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that Tim McCarthy, CEO, Dr Tim Franklin, COO, and Dr Sebastien Goudreau, CSO will be attending the forthcoming Bio-Europe Conference in Vienna, from 3-5 November 2025.
BIO-Europe Vienna 2025, is the 31st annual premier biopharma partnering event. It brings together over 5,700 life science professionals from more than 3,000 companies across 60+ countries, facilitating more than 30,000 one-to-one meetings. This event makes it the leading life science partnering forum in Europe, fostering innovation, collaboration and growth in the biotech sector.
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.